![]() IsoPlexis IsoPlexis is a company that develops a diagnostic platform for immunology research and therapeutic development. | ![]() Biocartis Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry. | ||
Founding Date | Founding Date 2013 | Founding Date 2007 | Founding Date 2010 |
Type | Type Subsidiary | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations Branford, US HQ Shanghai, CN Birmingham, GB | Locations Jersey City, US HQ Meadowbrook, AU Mechelen, BE Sofia, BG Huechuraba, CL Zagreb, HR Espoo, FI see more | Locations Carlsbad, US HQ Carlsbad, US |
Employees | Employees 29037% decrease | Employees 52614% increase | Employees 4402% increase |
Financial | |||
Revenue (est.) | Revenue (est.) $16.8m (FY, 2022) | Revenue (est.) €47.4m (FY, 2023) | Revenue (est.) $171.6m (FY, 2020) |
Cost of goods | Cost of goods $17.7m (FY, 2022) | Cost of goods €12.4m (FY, 2023) | Cost of goods $103.6m (FY, 2020) |
Gross profit | Gross profit ($925k) (FY, 2022) | Gross profit €35.3m (FY, 2023) | Gross profit $67.9m (FY, 2020) |
Net income | Net income ($106m) (FY, 2022) | Net income €18.4m (FY, 2023) | Net income ($18.6m) (FY, 2020) |
Funding | |||
Total funding raised | Total funding raised $ 171.8m | Total funding raised $ 321.2m | Total funding raised N/A |

Biocartis is an innovative commercial stage molecular diagnostics (MDx) company providing next generation diagnostic solutions aimed at improving clinical practice for the benefit of patients, clinicians, payers and industry.
View company
GenMark Diagnostics is a provider of multiplex molecular diagnostic solutions.
View company